Tamoxifen Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg and 20 mg

Reference Brands: Nolvadex(US & EU)

Category: Oncology Cancer Care

Tamoxifen is an oncology drug used for breast cancer treatment and prevention, available in 10 mg and 20 mg oral tablet strengths in the U.S. and EU. Under the brand name Nolvadex, it blocks estrogen’s effects on estrogen receptor-positive (ER+) breast cancer. Tamoxifen is essential in adjuvant therapy and for preventing breast cancer in high-risk patients, with both branded and generic versions available for B2B pharmaceutical distribution. Tamoxifen is available in Tablets and strengths such as 10 mg and 20 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tamoxifen is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Tamoxifen can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Tamoxifen is a widely used oncology drug for breast cancer treatment and prevention, primarily available as oral tablets in 10 mg and 20 mg strengths in the U.S. and EU. Under the brand name Nolvadex, Tamoxifen is a selective estrogen receptor modulator (SERM), effective in treating estrogen receptor-positive (ER+) breast cancer by blocking estrogen’s growth-promoting effects. It is available in both U.S. and EU markets with generic alternatives. Tamoxifen plays a critical role in adjuvant therapy and breast cancer prevention for high-risk patients. Its availability in oral form makes it suitable for B2B pharmaceutical distribution.